ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GSK Gsk Plc

1,707.40
2.20 (0.13%)
Last Updated: 08:35:24
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.20 0.13% 1,707.40 1,707.40 1,708.00 1,708.60 1,699.40 1,701.60 177,847 08:35:24
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 14.24 70.15B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,705.20p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £70.15 billion. Gsk has a price to earnings ratio (PE ratio) of 14.24.

Gsk Share Discussion Threads

Showing 19701 to 19723 of 33075 messages
Chat Pages: Latest  795  794  793  792  791  790  789  788  787  786  785  784  Older
DateSubjectAuthorDiscuss
21/6/2019
18:28
Steady Porche, can't have you criticising your beloved EU. Must be the only thing not to be the fault of Brexit!!
warranty
21/6/2019
16:53
Market report:

StockMarketWire.com - The FTSE 100 endured a downbeat end to the week, falling more than 0.5% as the pharmaceutical sector came under some pressure.

GlaxoSmithKline fell 1.3%, AstraZeneca was down 2% and Reckitt Benckiser slipped 1.8% on the threat of US government intervention in the healthcare space.

philanderer
21/6/2019
16:26
I sold all mine at 1610.5

Roll on 1525

:)

marksp2011
21/6/2019
15:55
tomorrow no change :-)
sicker
21/6/2019
15:30
Tomorrow back to 15 pounds
abdullla
21/6/2019
15:27
There must be bad news for pharmaceuticals,Ftse is only down just 20 points
abdullla
21/6/2019
15:15
Definitely dog of the day by a mile in my lot .
philanderer
21/6/2019
14:48
Have to agree selling at £16 and buying at £15 has to be one of the most predictable trades at present.
tim 3
21/6/2019
14:15
this is really tanking again now, EU sticking their nose where it isnt wanted.
porsche1945
21/6/2019
13:38
Blimey, some of you guys are using serious money here , puts my 700 shares into perspective :-)
philanderer
21/6/2019
13:35
---GSK is not a stock to be traded you just buy and hold

This made me laugh so much. I've been moving 300k+ in and out GSK for years now, sometimes more successfully than others. Let me guarantee you, you can trade this and make money. It's been reasonably predictable particularly over the last year or so, that is about to change though - forming the JV will start to throw in a very new dynamic.

romeike
21/6/2019
11:27
rubbish, its a perfect trading stock, completely range bound, you buy sub 1520 and sell 15.90 plus, I have done it extremely profitably numerous times over the last 18 months and am up just over 32k trading profits on gsk, plus some dividends, in fact if its dividends you want there are far better plays. It isnt a growth stock, this is no Astra.
porsche1945
21/6/2019
11:10
GSK is not a stock to be traded you just buy and hold
growthpotential
21/6/2019
10:47
Never mind there is always the dividend to hope for.
abdullla
21/6/2019
10:44
Just greed,I am disgusted.
abdullla
21/6/2019
09:49
abdulla - what were you waiting for? You had two chances. ;-)
solomon
21/6/2019
09:48
Knocked off the number one spot in my portfolio this morning.

Didn't last long ;-)

philanderer
21/6/2019
08:49
A 40p drop from the high of yesterday,missed my sell @1615p.
abdullla
21/6/2019
08:15
.....and back to 15.20....
porsche1945
20/6/2019
18:40
Glaxo offers concessions to address Pfizer deal concerns

The European Commission says GlaxoSmithKline (NYSE:GSK) has offered concessions to address European Union antitrust concerns over its planned joint venture with Pfizer's (NYSE:PFE) consumer health business.

The EU competition enforcer will decide by July 10 whether to accept the proposal or open a full-scale investigation.

GSK and PFE announced their JV plans late last year, and GSK said at the time it aimed to divest assets worth ~£1B during 2019-20.

crossing_the_rubicon
20/6/2019
18:27
With TATE going xd today , GSK is now my largest holding :-)
philanderer
20/6/2019
15:32
Home sweet home.
abdullla
20/6/2019
15:18
Red's fine, just stay above 1600. Make yourself comfortable. This is your new home.
thamestrader
Chat Pages: Latest  795  794  793  792  791  790  789  788  787  786  785  784  Older

Your Recent History

Delayed Upgrade Clock